HDAC3 and pulmonary fibrosis: Moreover, AT2-specific deletion of HDAC3 or intraperitoneal injection of the selective HDAC3 inhibitor, RGFP966, significantly alleviated EMT in mice with BLM-induced pulmonary fibrosis.